Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Pollard

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Biochimica Et Biophysica Acta|February 19, 2013
Kinetic and mechanistic characterisation of Choline Kinase-αCatherine S Hudson, Ronald M Knegtel, Kieron Brown, et al.
Molecular Oncology|December 3, 2014
Development of pharmacodynamic biomarkers for ATR inhibitorsTao Chen, Fiona K Middleton, Susanna Falcon, et al.
Seizure|December 21, 2013
Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depressionKatherine T Hamilton, Christopher T Anderson, Nabila Dahodwala, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2011
Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fracturesHedi Schelleman, John R Pollard, Craig Newcomb, et al.
Journal of Thrombosis and Thrombolysis|July 9, 2002
Vertebrobasilar thrombolysis with intravenous tirofiban: case reportDavid S Liebeskind, John R Pollard, Eric D Schwartz, et al.
Neurology|January 26, 2021
Association of Epileptic and Nonepileptic Seizures and Changes in Circulating Plasma Proteins Linked to NeuroinflammationJohn M Gledhill, Elizabeth J Brand, John R Pollard, et al.
Epilepsy & Behavior : E&B|November 26, 2020
Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010-2018Emily K Acton, Michael A Gelfand, Sean Hennessy, et al.
Neurology|July 12, 2019
Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)Dorothee G A Kasteleijn-Nolst Trenite, Bree D DiVentura, John R Pollard, et al.
Cancer Biology & Therapy|July 25, 2012
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapyRemko Prevo, Emmanouil Fokas, Philip M Reaper, et al.
Nature Chemical Biology|April 15, 2011
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATRPhilip M Reaper, Matthew R Griffiths, Joanna M Long, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|February 19, 2013
Kinetic and mechanistic characterisation of Choline Kinase-αCatherine S Hudson, Ronald M Knegtel, Kieron Brown, et al.
Molecular Oncology|December 3, 2014
Development of pharmacodynamic biomarkers for ATR inhibitorsTao Chen, Fiona K Middleton, Susanna Falcon, et al.
Seizure|December 21, 2013
Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depressionKatherine T Hamilton, Christopher T Anderson, Nabila Dahodwala, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2011
Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fracturesHedi Schelleman, John R Pollard, Craig Newcomb, et al.
Journal of Thrombosis and Thrombolysis|July 9, 2002
Vertebrobasilar thrombolysis with intravenous tirofiban: case reportDavid S Liebeskind, John R Pollard, Eric D Schwartz, et al.
Neurology|January 26, 2021
Association of Epileptic and Nonepileptic Seizures and Changes in Circulating Plasma Proteins Linked to NeuroinflammationJohn M Gledhill, Elizabeth J Brand, John R Pollard, et al.
Epilepsy & Behavior : E&B|November 26, 2020
Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010-2018Emily K Acton, Michael A Gelfand, Sean Hennessy, et al.
Neurology|July 12, 2019
Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)Dorothee G A Kasteleijn-Nolst Trenite, Bree D DiVentura, John R Pollard, et al.
Cancer Biology & Therapy|July 25, 2012
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapyRemko Prevo, Emmanouil Fokas, Philip M Reaper, et al.
Nature Chemical Biology|April 15, 2011
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATRPhilip M Reaper, Matthew R Griffiths, Joanna M Long, et al.
Pageof 4